US$ 27.27
glp-1 therapies GLP-1-based for diabetes, obesity and beyond GLP-1 Drugs and Weight Loss:
Description
It is complex to navigate all the information online and hard to know what to trust

While early GLP1 drugs focused primarily on diabetes, newer agents, such as tirzepatidebased therapies, have gained traction in treating obesity, raising efficacy expectations and increasing competitive dynamics
However, these latest findings suggest that GLP-1 drugs may help prevent this complication

Based on hazard ratios, this equates to roughly a 58% increased risk of developing all thyroid cancers and a 78% increased risk of developing medullary thyroid cancer compared to controls

Images were obtained with 20 objective by an inverted Nikon TMS-F microscope (Nikon Instruments, Irving, TX, USA)
